Non-rebreather at Flush Rate Compared to Bag Valve Mask With Assist
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02841592|
Recruitment Status : Completed
First Posted : July 22, 2016
Last Update Posted : January 30, 2018
|Condition or disease||Intervention/treatment||Phase|
|Acute Respiratory Failure||Other: Flush rate oxygen Other: Flush rate oxygen with assist||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||27 participants|
|Intervention Model:||Crossover Assignment|
|Masking:||None (Open Label)|
|Actual Study Start Date :||July 2016|
|Actual Primary Completion Date :||August 2016|
|Actual Study Completion Date :||August 2016|
Active Comparator: Non-rebreather
This group will have a non-rebreather mask applied to the face and they will receive the flush rate oxygen intervention
Other: Flush rate oxygen
Using a standard flowmeter (Precision Medical, 8MFA), the flow of oxygen will be fully opened and oxygen will be administered for three minutes.
Active Comparator: Bag-valve-mask
With each inspiration from the subject, the ventilation bag will be gently squeezed to provide positive pressure and augment the amount of oxygen that is received by the subject for each breath. This group will receive the flush rate oxygen with assist intervention.
Other: Flush rate oxygen with assist
Using a standard flowmeter (Precision Medical, 8MFA), the flow of oxygen will be fully opened and oxygen will be administered for three minutes. Positive pressure breaths to match the subject's inspiration will be provided during the three minute period.
- Fraction of expired oxygen [ Time Frame: 3 minutes ]The fraction of expired oxygen will be measured after three minutes of preoxygenation
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02841592
|United States, Minnesota|
|Hennepin County Medical Center|
|Minneapolis, Minnesota, United States, 55415|